Report
Nikolaas Faes

Initiation of Coverage | FLOWR | “La Vie en Rose” | BUY, CAD3.5

Initiation of Coverage | FLOWR | “La Vie en Rose” | BUY, CAD3.5

Flowr is a Canadian and European Licensed Cannabis Producer differentiated with on the one hand exposure to the premium end of the Canadian recreational cannabis market and on the other hand large scale low-cost cultivation in Portugal for the European and global medical cannabis market under EU-GMP certification. We are initiating the company with a Buy rating and a fair value of CAD3.3 per share.
Underlying
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Nikolaas Faes

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch